COVID-19 Vaccine Update: What To Do If You’re Struggling
- This article details meaningful hurdles to accessing the updated COVID-19 vaccines in the fall of 2025, stemming from changes made under the Trump administration.
- * The FDA, under a Trump-appointed commissioner, has limited vaccine access to those 65 years and older or individuals with chronic medical conditions.
- * The CDC has been significantly impacted by staff layoffs (over 2,000 employees) and leadership turnover under the Trump administration.
Summary of Challenges to COVID-19 Vaccine Access (as of late September 2025)
This article details meaningful hurdles to accessing the updated COVID-19 vaccines in the fall of 2025, stemming from changes made under the Trump administration. Here’s a breakdown of the three main challenges:
1. Restricted FDA Approval:
* The FDA, under a Trump-appointed commissioner, has limited vaccine access to those 65 years and older or individuals with chronic medical conditions.
* Those under 65 will likely need documentation (a doctor’s note or prescription) proving a qualifying chronic condition to receive the vaccine. Simply having received prior vaccinations won’t be sufficient.
* Qualifying conditions include asthma, cancer, heart conditions, diabetes, obesity, and immune system disorders, among others.
2. CDC Disarray & Lack of guidance:
* The CDC has been significantly impacted by staff layoffs (over 2,000 employees) and leadership turnover under the Trump administration.
* The confirmed CDC Director was “fired” after only a month on the job,and the agency is currently led by an acting director without a scientific or public health background.
* The Advisory Committee on Immunization Practices (ACIP), responsible for advising the CDC on vaccine recommendations, has been completely replaced by appointees chosen by Health and Human Services Secretary Robert F. Kennedy, Jr.
* The ACIP is not meeting until september 18-19, delaying official CDC guidance.
* Some states (like California and New York) are issuing their own guidance, but at least 18 states typically wait for CDC recommendations, potentially requiring prescriptions even for those over 65.
3. Insurance Coverage Uncertainty:
* Pfizer and Moderna have increased vaccine prices now that federal funding has ended.
* Federal law typically requires insurers to cover CDC-recommended vaccines.
* However, due to the delayed ACIP meeting and lack of official CDC recommendation, it’s unclear which insurers will cover the updated vaccines.
Key Takeaway: The author emphasizes that getting vaccinated in October is crucial to gain protection before the expected November COVID-19 surge, but significant obstacles currently stand in the way of easy access.